Journal
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Volume 158, Issue -, Pages 62-71Publisher
ELSEVIER
DOI: 10.1016/j.ejpb.2020.11.001
Keywords
Gene delivery; Poly(hexamethylene biguanide) (PHMB); Nanoparticles; Self-assembly
Categories
Funding
- Biotechnology and Biological Sciences Research Council [BBSRC LIDo DTP studentship]
- Engineering and Physical Sciences Research Council in the United Kingdom [EP/L020904/1, EP/M026884/1, EP/R02961X/1]
Ask authors/readers for more resources
This study demonstrates the efficient intracellular delivery of pDNA and ODNs using PHMB as a nano-vector, with comparable or even higher gene expression levels than PEI analogues in various cell lines. The well-established safety profile of PHMB makes it a promising candidate for further research and potential clinical applications.
Cellular gene delivery via polycations has wide implications for the potential of gene therapy, but it has remained a challenge due to the plethora of preand post-uptake barriers that must be overcome to reach desired efficiency. Herein we report poly(hexamethylene biguanide) (PHMB) as a nano-vector for intracellular delivery of plasmid DNA (pDNA) and oligodeoxynucleotides (ODNs). PHMB and pDNA or ODNs self-assembled into complex nanoparticles at different pH values (7.4 and 12). Their size, charge, cellular uptake, and gene-expression efficiency are assessed and compared to PEI analogues. The systematic results show that the nanoparticles are effective in delivering plasmid DNA and ODNs to model cell lines in culture (HepG2, HEK293T, HeLa), with measurable changes in gene expression levels, comparable to and, in some conditions, even higher than PEI. The well-accepted safety profile of PHMB makes it a valuable candidate for consideration as an effective intracellular DNA vector for further study and potential clinical translation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available